These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 29240618)

  • 1. Diagnosing and treating ADHD in adults.
    Scrandis DA
    Nurse Pract; 2018 Jan; 43(1):8-10. PubMed ID: 29240618
    [No Abstract]   [Full Text] [Related]  

  • 2. [Attention deficit-hyperactivity disorder (ADHD); etiology, diagnosis and treatment].
    't Jong GW; van den Anker JN
    Ned Tijdschr Geneeskd; 2000 Nov; 144(46):2227-8. PubMed ID: 11103263
    [No Abstract]   [Full Text] [Related]  

  • 3. Methylphenidate versus dextroamphetamine in ADHD.
    Efron D
    J Am Acad Child Adolesc Psychiatry; 1999 May; 38(5):500. PubMed ID: 10230180
    [No Abstract]   [Full Text] [Related]  

  • 4. Case of a 67-year-old woman diagnosed with ADHD successfully treated with methylphenidate.
    da Silva MA; Louza M
    J Atten Disord; 2008 May; 11(6):623. PubMed ID: 18417727
    [No Abstract]   [Full Text] [Related]  

  • 5. Trends in the prescribing of stimulant medication for the treatment of Attention Deficit Hyperactivity Disorder in adults in New South Wales.
    New South Wales Department of Health
    N S W Public Health Bull; 2004; 15 Suppl 3():1-55. PubMed ID: 15448720
    [No Abstract]   [Full Text] [Related]  

  • 6. Neuroendocrine responses to methylphenidate and d-amphetamine: applications to attention-deficit disorder.
    Lurie S; O'Quinn A
    J Neuropsychiatry Clin Neurosci; 1991; 3(1):41-50. PubMed ID: 7580171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attention deficit hyperactivity disorder, combined type: better executive function performance with longer-term psychostimulant medication.
    Vance AL; Maruff P; Barnett R
    Aust N Z J Psychiatry; 2003 Oct; 37(5):570-6. PubMed ID: 14511085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical considerations for the diagnosis and treatment of ADHD in the managed care setting.
    Jensen PS
    Am J Manag Care; 2009 May; 15(5 Suppl):S129-40. PubMed ID: 19601688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefit of long-term stimulants on driving in adults with ADHD.
    Jerome L; Segal A
    J Nerv Ment Dis; 2001 Jan; 189(1):63-4. PubMed ID: 11206669
    [No Abstract]   [Full Text] [Related]  

  • 10. A review of studies of drug treatment efficacy for attention deficit disorder with hyperactivity in adolescents.
    Varley CK
    Psychopharmacol Bull; 1985; 21(2):216-21. PubMed ID: 2860692
    [No Abstract]   [Full Text] [Related]  

  • 11. Attention deficit hyperactivity disorder in children.
    Ramchandani P; Joughin C; Zwi M
    Clin Evid; 2002 Jun; (7):262-71. PubMed ID: 12230649
    [No Abstract]   [Full Text] [Related]  

  • 12. Methylphenidate vs dexamphetamine: a clinical audit.
    Green C
    J Paediatr Child Health; 1996 Oct; 32(5):470. PubMed ID: 8933415
    [No Abstract]   [Full Text] [Related]  

  • 13. Attention deficit hyperactivity disorder in children.
    Ramchandani P; Joughin C; Zwi M
    Clin Evid; 2002 Dec; (8):280-90. PubMed ID: 12603883
    [No Abstract]   [Full Text] [Related]  

  • 14. Does collateral retrospective information about childhood attention-deficit/hyperactivity disorder symptoms assist in the diagnosis of attention-deficit/hyperactivity disorder in adults? Findings from a large clinical sample.
    Breda V; Rovaris DL; Vitola ES; Mota NR; Blaya-Rocha P; Salgado CA; Victor MM; Picon FA; Karam RG; Silva KL; Rohde LA; Bau CH; Grevet EH
    Aust N Z J Psychiatry; 2016 Jun; 50(6):557-65. PubMed ID: 26460329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Basics of the drug therapy for attention deficit hyperactivity disorders in adolescents].
    Airaksinen E; Airaksinen MM
    Duodecim; 2003; 119(16):1553-62. PubMed ID: 14535028
    [No Abstract]   [Full Text] [Related]  

  • 16. European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder.
    Coghill D; Banaschewski T; Lecendreux M; Soutullo C; Johnson M; Zuddas A; Anderson C; Civil R; Higgins N; Lyne A; Squires L
    Eur Neuropsychopharmacol; 2013 Oct; 23(10):1208-18. PubMed ID: 23332456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Illicit use of prescription ADHD medications on a college campus: a multimethodological approach.
    DeSantis AD; Webb EM; Noar SM
    J Am Coll Health; 2008; 57(3):315-24. PubMed ID: 18980888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulant treatment of adult attention-deficit/hyperactivity disorder.
    Spencer T; Biederman J; Wilens T
    Psychiatr Clin North Am; 2004 Jun; 27(2):361-72. PubMed ID: 15064002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulant therapy in attention deficit/hyperactivity disorder.
    Baldwin RL
    J Ark Med Soc; 2003 Dec; 100(6):203-6. PubMed ID: 14661403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of stimulant medications on children with attention-deficit/hyperactivity disorder and excessive beta activity in their EEG.
    Clarke AR; Barry RJ; McCarthy R; Selikowitz M; Clarke DC; Croft RJ
    Clin Neurophysiol; 2003 Sep; 114(9):1729-37. PubMed ID: 12948803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.